Cargando…

Metabolic effects of adding Topiramate on Aripiprazole in bipolar patients aged between 6-18 years, a randomized, double-blind, placebo-controlled trial

BACKGROUND: second-generation antipsychotics (SGAs) are associated with metabolic side effects in child and adolescents. The aim of this study is to evaluate the metabolic effects of adding topiramate on aripiprazole in patients with bipolar disorder (BD) aged between 6 and 18 years. MATERIALS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arman, Soroor, Haghshenas, Mostafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995310/ https://www.ncbi.nlm.nih.gov/pubmed/35419064 http://dx.doi.org/10.4103/jrms.jrms_672_21

Ejemplares similares

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
por: Raghuthaman, G., et al.
Publicado: (2015)

Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study
por: Muzina, D J, et al.
Publicado: (2008)

Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
por: Afshar, Hamid, et al.
Publicado: (2014)

Decrease in tobacco consumption after treatment with topiramate and aripiprazole: a case report
por: Arbaizar, Beatriz, et al.
Publicado: (2008)

Topiramate precipitating mania in bipolar disorder
por: Uvais, NA, et al.
Publicado: (2016)

Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study
por: Consoli, Angèle, et al.
Publicado: (2019)

A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder
por: Mello, Marcelo Feijó, et al.
Publicado: (2009)

Psychopharmacology of topiramate: from epilepsy to bipolar disorder
por: Mula, Marco, et al.
Publicado: (2006)

Comparison of Aripiprazole and Risperidone effectiveness in treating obsessive‐compulsive disorder in patients with bipolar disorder: Double‐blind, randomized clinical trial
por: Khorshidian, Faezeh, et al.
Publicado: (2023)

Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents
por: Sallee, Floyd, et al.
Publicado: (2017)

Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study
por: Ichikawa, Hironobu, et al.
Publicado: (2016)

Double‐blind, placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression
por: Kato, Tadafumi, et al.
Publicado: (2020)

Aripiprazole in the acute and maintenance phase of bipolar I disorder
por: Zupancic, Melanie, et al.
Publicado: (2012)

When to start aripiprazole therapy in patients with bipolar mania
por: Sayyaparaju, Kiran Kumar, et al.
Publicado: (2014)

Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents
por: Kirino, Eiji
Publicado: (2014)

Parenting Styles and Psychiatric Disorders in Children of Bipolar Parents
por: Arman, Soroor, et al.
Publicado: (2018)

The Efficacy of Augment of D-Cycloserine and Cognitive-behavioral Therapy on Adolescent with one Type of Anxiety Disorders: A Double-blind Randomized Controlled Trial
por: Arman, Soroor, et al.
Publicado: (2017)

Treatment with aripiprazole and topiramate in an obese subject with borderline personality disorder, obsessive-compulsive symptoms and bulimia nervosa: a case report
por: Bruno, Antonio, et al.
Publicado: (2009)

Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
por: Fagiolini, Andrea
Publicado: (2010)

Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2010)

Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
por: Muzina, David J
Publicado: (2009)

The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review
por: Muneer, Ather
Publicado: (2016)

Comparison the effectiveness of aripiprazole and risperidone for the treatment of acute bipolar mania
por: Rezayat, Amir Akhavan, et al.
Publicado: (2014)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study
por: Wani, Rayees Ahmad, et al.
Publicado: (2015)

Cinnarizine versus Topiramate in Prophylaxis of Migraines among Children and Adolescents: A Randomized, Double-Blind Clinical Trial
por: ASHRAFI, Mahmoud Reza, et al.
Publicado: (2014)

Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial
por: Reuter, Uwe, et al.
Publicado: (2021)

Efficacy of Group Cognitive–behavioral Therapy in Maintenance Treatment and Relapse Prevention for Bipolar Adolescents
por: Arman, Soroor, et al.
Publicado: (2018)

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
por: McIntyre, Roger S, et al.
Publicado: (2011)

A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder
por: Citrome, Leslie
Publicado: (2006)

Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2009)

Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder
por: Amerio, Andrea, et al.
Publicado: (2018)

Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder
por: Di Salvo, Gabriele, et al.
Publicado: (2020)

The frequency and severity of metabolic acidosis related to topiramate
por: Türe, Hatice, et al.
Publicado: (2016)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
Publicado: (2015)

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
por: Berk, Michael, et al.
Publicado: (2012)

Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study
por: Earley, Willie R., et al.
Publicado: (2019)

The Efficacy of Probiotics for Treatment of Bipolar Disorder-Type 1: A Randomized, Double-Blind, Placebo Controlled Trial
por: Eslami Shahrbabaki, Mahin, et al.
Publicado: (2020)

Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2009)

Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2010)

Aripiprazole as augmentation therapy in bipolar patients with current minor or subsyndromal mood symptoms
por: Schweitzer, Isaac, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1fb7brdsntg4qge5ksonlchv1k